Scilit vs Rayyan (2026)

Scilit

by MDPI

Rayyan

by Rayyan

Pros

• ✓Fully free for all users with no subscription tiers — accessible to researchers in any region and institution without budget barriers, materially better than Web of Science or Scopus that require expensive institutional subscriptions
• ✓Comprehensive coverage at scale — 187M publications and 2.2B citations match or exceed commercial competitors at zero cost, materially better unit economics for individual researchers and resource-constrained institutions
• ✓Strong open-access focus with 47M OA articles and 8M preprints — better OA coverage than commercial databases that focus primarily on subscription content, valuable for OA-committed researchers and emerging-discipline coverage

Limitations

• ⚠MDPI ownership creates editorial independence considerations — MDPI's broader publishing operations have faced academic scrutiny over predatory journal allegations, with implications for Scilit's perceived independence and ranking methodology that researchers should evaluate carefully
• ⚠Less workflow depth than commercial alternatives — Scilit is purpose-built for search and discovery but lacks the citation analysis tools, journal impact metrics, and research analytics that Web of Science or Scopus provide for sophisticated bibliometric work
• ⚠No AI agent capabilities or LLM integration — Scilit provides traditional database access without modern AI research agent features (synthesis, summarization, autonomous research) that AI research tools (Elicit, SciSpace, Gemini Deep Research) provide for accelerated workflows

Pros

• ✓Academic-friendly pricing with free tier and student tier is genuinely differentiated — Free for early-career researchers and $4.99/seat student tier make systematic review tools accessible to individual researchers and graduate students that find Covidence or DistillerSR enterprise pricing prohibitive
• ✓Industry-leading duplicate detection — Rayyan's duplicate detection is widely regarded as the best in the systematic review category, materially better than alternatives that produce more false negatives in deduplication
• ✓1M+ researcher installed base provides community resources and validation — extensive global adoption produces materially more learning materials, peer references, and methodology examples than smaller systematic review alternatives

Limitations

• ⚠Less depth than enterprise systematic review tools (Covidence, DistillerSR) — Rayyan is solid for academic and SMB systematic review but lacks the workflow customization, advanced reporting, and enterprise-specific features that dedicated commercial alternatives provide for high-stakes regulatory and clinical work
• ⚠Free tier limits create scaling friction — 3 active reviews and 2 reviewers per review on Free tier require upgrade for active research teams, meaningful for cost-conscious individual researchers but limiting for productive research operations
• ⚠Specialized for systematic reviews limits broader research use cases — Rayyan is purpose-built for evidence synthesis and lacks the broader literature search, citation analysis, and AI research capabilities that horizontal AI research tools (Elicit, Scite.ai, SciSpace) provide